Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.

Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.

BACKGROUND: Functional imaging using (123)I-meta-iodo-benzyl-guanetidine (MIBG) scintigraphy has alleged 100% specificity for phaeochromocytoma (PHAEO). Its benefit in patients with biochemical diagnosis of PHAEO is arguable when cross-sectional radiology can demonstrate the side-size of the adrena...

Full description

Bibliographic Details
Main Authors:	Mihai, R, Gleeson, F, Roskell, D, Parker, A, Sadler, G
Format:	Journal article
Language:	English
Published:	2008

Similar Items

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
by: Bhatia, K, et al.
Published: (2008)

123I-MIBG Myocardial Scintigraphy in the Diagnosis of Lewy Body Dementia
by: M. Marquié Sayagués, et al.
Published: (2010-01-01)

Cardiac 123I-MIBG scintigraphy and arrhythmic risk in left ventricular noncompaction
by: Sílvia Marta Oliveira, et al.
Published: (2012-03-01)

MIBG scans for phaeochromocytoma: time to abandon the technique?
by: Grossman, A, et al.
Published: (2009)

Value of multi-parameter 123I-MIBG scintigraphy in the differential diagnosis of Parkinson’s disease
by: Teng Xue, et al.
Published: (2025-01-01)

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
by: Jamir Pitton Rissardo, et al.
Published: (2023-10-01)

Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
by: Nagahisa Murakami, et al.
Published: (2019-04-01)

Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice
by: Cornelia Skowronek, et al.
Published: (2019-02-01)

Recognition of Abnormal Uptake through 123I-mIBG Scintigraphy Entropy for Paediatric Neuroblastoma Identification
by: Milagros Martínez-Díaz, et al.
Published: (2016-09-01)

Clinical perspectives of using scintigraphy with 123-1-MIBG for assessment of sympathetic nervous system of the myocardium
by: I V Sergienko, et al.
Published: (2003-04-01)

Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
by: Yuiko Inaba, et al.
Published: (2022-06-01)

131I-MIBG myocardial scintigraphy in patients with Parkinson's disease
by: Tuan-feng YANG, et al.
Published: (2016-06-01)

Efeito do carvedilol a curto prazo na atividade simpática cardíaca pela cintilografia com 123I-MIBG Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy
by: Sandra Marina Ribeiro de Miranda, et al.
Published: (2010-03-01)

Cardiac 131I-MIBG scintigraphy in patients with multiple system atrophy
by: Li WANG, et al.
Published: (2014-03-01)

Author Correction: Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
by: Yuiko Inaba, et al.
Published: (2022-08-01)

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease
by: Yoshitaka Kumakura, et al.
Published: (2021-12-01)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
by: Nastos, K, et al.
Published: (2017)

Comparative Study between the Diagnostic Effectiveness of Brain SPECT with [<sup>123</sup>I]Ioflupane and [<sup>123</sup>I]MIBG Scintigraphy in Multiple System Atrophy
by: Javier Villena-Salinas, et al.
Published: (2024-01-01)

Elevated Heart Rate is Associated with Cardiac Denervation in Patients with Heart Failure: A 123-Iodine-MIBG Myocardial Scintigraphy Study
by: Aline Sterque Villacorta, et al.

Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease
by: Jörg Spiegel
Published: (2010-01-01)

Exploring Cardiac Sympathetic Denervation in Transthyretin-Mediated Hereditary Amyloidosis (ATTRv): Insights from <sup>123</sup>I-mIBG Scintigraphy
by: Maria Silvia De Feo, et al.
Published: (2025-02-01)

Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review
by: Ming-Cheng Chang, et al.
Published: (2024-11-01)

Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease
by: Cecilia Boccalini, et al.
Published: (2022-12-01)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
by: Mukherjee, J, et al.
Published: (2001)

Value of 123I-MIBG SPECT for the assessment of dysautonomia in patients with long COVID
by: Adriana S. Xavier de Brito, et al.
Published: (2024-06-01)

Thyroid [123I]MIBG uptake in Parkinson’s disease and diabetes mellitus
by: Tatyana D. Fedorova, et al.
Published: (2023-06-01)

Erratum: Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson's disease
by: Frontiers Production Office
Published: (2023-03-01)

Myocardial 123I-MIBG Uptake and Cardiovascular Autonomic Function in Parkinson’s Disease
by: Akira Katagiri, et al.
Published: (2015-01-01)

Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
by: Hiroshi Wakabayashi, et al.
Published: (2019-06-01)

Longitudinal changes in cardiac mIBG scintigraphy in mild cognitive impairment with Lewy bodies
by: Gemma Greenfinch, et al.
Published: (2024-11-01)

Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
by: Joachim Brumberg, et al.
Published: (2020-12-01)

Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
by: Hiroshi Mori, et al.
Published: (2024-06-01)

Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
by: Samuel L. Brady, et al.
Published: (2019-12-01)

Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson’s Disease
by: Heisuke Mizukami, et al.
Published: (2024-05-01)

Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
by: Hiroshi Mori, et al.
Published: (2024-08-01)

Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
by: Maria Silvia De Feo, et al.
Published: (2023-08-01)

False Positive Radioiodinated Metaiodobenzylguanidine (123I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor
by: Hee Soo Jung, et al.
Published: (2015-01-01)

Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.
by: Young Jin Jeong, et al.
Published: (2020-01-01)

Renal <sup>123</sup>I-MIBG Uptake before and after Live-Donor Kidney Transplantation
by: Thomas Rasmussen, et al.
Published: (2020-10-01)

Biological Distribution of Orally Administered [<sup>123</sup>I]MIBG for Estimating Gastrointestinal Tract Absorption
by: Masato Kobayashi, et al.
Published: (2021-12-01)